NIP
TIL icon

Nicholas Investment Partners’s Instil Bio TIL Stock Holding History

Nicholas Investment Partners’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-44,869
Closed -$4.34M – 197
2022
Q3 		$4.34M Buy
44,869
+22,691
+102% +$2.6M 0.4% 82
2022
Q2 		$2.05M Sell
22,178
-15,941
-42% -$2.26M 0.19% 126
2022
Q1 		$8.2M Buy
38,119
+2,458
+7% +$574K 0.58% 57
2021
Q4 		$12.2M Buy
35,661
+1,702
+5% +$657K 0.77% 48
2021
Q3 		$12.1M Sell
33,959
-8,682
-20% -$3.24M 0.89% 40
2021
Q2 		$16.5M Buy
42,641
+15,162
+55% +$5.62M 1.03% 34
2021
Q1 		$13.8M Buy
+27,479
New +$14.1M 0.96% 44

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nicholas Investment Partners's TIL Position: Q4 2022 in Review

Nicholas Investment Partners sold out of Instil Bio (TIL) in Q4 2022, closing a stake of 44,869 shares — an estimated $4.34M sold.

Nicholas Investment Partners first reported a position in TIL in Q1 2021 and held it in 7 quarters. The position peaked at $16.5M in Q2 2021. 78 funds tracked by Wall St. Rank hold TIL as of Q4 2022.

  • Nicholas Investment Partners reported no remaining Instil Bio position as of Q4 2022 after selling out during the quarter.
  • Nicholas Investment Partners sold 44,869 Instil Bio shares in Q4 2022, an estimated $4.34M.
  • Nicholas Investment Partners first reported a position in Instil Bio in Q1 2021 and held it in 7 quarters.
  • Nicholas Investment Partners's Instil Bio position peaked at $16.5M in Q2 2021.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q4 2022.

Based on Nicholas Investment Partners's 13F filing for Q4 2022, filed 10 Feb 2023.